Dave Yeung, Ph.D. is a Scientific Project Manager for the NIH Countermeasures Against Chemical Threats (CounterACT) Program within the Office of Translational Research, National Institute of Neurological Disorders and Stroke (NINDS). Dr. Yeung received his Ph.D. in Medical Pharmacology and Experimental Therapeutics from the University of Maryland School of Medicine in Baltimore and a B.S. in Cellular & Developmental Biology from the University of Rochester.
Prior to joining the CounterACT Program, Dr. Yeung was a researcher at the U.S. Army Medical Research Institute of Chemical Defense (USAMRICD). At USAMRICD, Dr. Yeung gained valuable experience in the research and development of medical countermeasures against classical chemical warfare agents, such as sulfur mustard, tabun, soman, sarin, VX, and VR, that led to the publication of multiple peer-reviewed manuscripts and book chapters. Additionally, Dr. Yeung was a co-author of a CounterACT U54 Center of Research Excellence (Center for Catalytic Bioscavenger Medical Defense Research) grant that was awarded to USAMRICD in 2006. Dr. Yeung joined NINDS and the NIH CounterACT Program in late 2007.
As a member of the CounterACT Program, Dr. Yeung serves as the primary program officer for the CounterACT R21 Exploratory research program and is the Task Order Scientific POC for the Efficacy Research Facility program. Additionally, Dr. Yeung assists the Program Director in the daily management and scientific oversight of the CounterACT research portfolio and works closely with the Office of Biodefense Research at NIAID.
In addition to his duties with CounterACT, Dr. Yeung also serves as a subject matter expert (SME) reviewing research applications, contracts, and white papers for federal agencies such as the Department of Defense Joint Science and Technology Office for Chemical and Biological Defense Science and Technology (DOD JSTO-CBD S&T) Program, Defense Threat Reduction Agency (DTRA), and the Department of Health and Human Services Biomedical Advanced Research and Development Authority (HHS BARDA). Dr. Yeung is also a member of several Integrated Product Teams (IPTs) and Working Groups (WGs) throughout the federal government.
Last Modified February 11, 2014